Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Undersea Hyperb Med ; 44(3): 257-269, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28779582

RESUMO

Traumatic brain injury (TBI) may cause persistent cognitive dysfunction. A pilot clinical study was performed to determine if hyperbaric oxygen (HBO2) treatment improves cognitive performance. It was hypothesized that stem cells, mobilized by HBO2 treatment, are recruited to repair damaged neuronal tissue. This hypothesis was tested by measuring the relative abundance of stem cells in peripheral blood and cognitive performance during this clinical trial. The subject population consisted of 28 subjects with persistent cognitive impairment caused by mild to moderate TBI suffered during military deployment to Iraq or Afghanistan. Fluorescence-activated cell sorting (FACS) analysis was performed for stem cell markers in peripheral blood and correlated with variables resulting from standard tests of cognitive performance and post-traumatic stress disorder: ImPACT, BrainCheckers and PCL-M test results. HBO2 treatment correlated with stem cell mobilization as well as increased cognitive performance. Together these results support the hypothesis that stem cell mobilization may be required for cognitive improvement in this population.


Assuntos
Lesões Encefálicas Traumáticas/terapia , Movimento Celular/fisiologia , Transtornos Cognitivos/terapia , Cognição/fisiologia , Oxigenoterapia Hiperbárica , Militares , Células-Tronco Neurais/fisiologia , Antígeno AC133 , Campanha Afegã de 2001- , Antígenos CD34 , Lesões Encefálicas Traumáticas/sangue , Lesões Encefálicas Traumáticas/complicações , Transtornos Cognitivos/sangue , Transtornos Cognitivos/etiologia , Método Duplo-Cego , Citometria de Fluxo , Humanos , Guerra do Iraque 2003-2011 , Nestina/análise , Projetos Piloto , Estatísticas não Paramétricas
2.
Burns ; 40(4): 759-71, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24290856

RESUMO

Opioid-related side effects are problematic for burn patients. Dual mechanism therapeutics targeting opioid and non-opioid mechanisms may have reduced side effects with similar analgesic efficacy. Tramadol combines mu opioid receptor agonism with norepinephrine reuptake inhibition and has been effective in treating some types of pain. The effectiveness of tramadol in treating pain associated with burns is unclear. We hypothesized that tramadol is effective in reducing thermal injury-evoked pain behaviors in a rat model. Rats were anesthetized and a 100°C metal probe was placed on the hindpaw for 30 s to induce a full thickness thermal injury. A subset of rats was perfusion fixed and hindpaw tissue and spinal cord collected for anatomical analysis. Rats received morphine (5 mg/kg; i.p.), tramadol (10-30 mg/kg; i.p.) or vehicle and latency to paw withdrawal from a noxious thermal or non-noxious mechanical stimulus was recorded every 10 min over 70 min and again at 2 h. We report that pain behaviors developed within 48 h and peaked at 1 week; paralleled by enhanced expression of pronociceptive neuropeptides in the spinal cord. Morphine and tramadol significantly attenuated hyperalgesia and allodynia, while not significantly altering motor coordination/sedation. These data indicate dual mechanism therapeutics may be effective for treating pain associated with burns.


Assuntos
Analgésicos Opioides/farmacologia , Queimaduras/metabolismo , Peptídeo Relacionado com Gene de Calcitonina/metabolismo , Hiperalgesia/metabolismo , Morfina/farmacologia , Nociceptividade/efeitos dos fármacos , Medula Espinal/metabolismo , Substância P/metabolismo , Tramadol/farmacologia , Animais , Comportamento Animal , Queimaduras/complicações , Queimaduras/patologia , Modelos Animais de Doenças , Hiperalgesia/etiologia , Masculino , Dor Nociceptiva/etiologia , Dor Nociceptiva/metabolismo , Dor/etiologia , Dor/metabolismo , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...